IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Saturday, 20 November 2021

The U.S. Funding of the Moderna mRNA Technology and a Patent Dispute

›
Ana Santos Rutschman at Saint Louis University Law School has authored an interesting short article titled, "Why Moderna Won't Sha...
Friday, 12 November 2021

The TRIPS Trap Revisited

›
By Roya Ghafele, OxFirst The World Trade Organization’s Trade-Related Aspects of Intellectual Property Rights  ( TRIPS) Agreement forced ...
Saturday, 6 November 2021

U.S. DOJ Settles Generic Drug Price Fixing Cases -- Over $400 million

›
The U.S. Department of Justice has settled several lawsuits concerning essentially of illegal price fixing between companies offering generi...
Thursday, 4 November 2021

Morrison and Foerster Sponsors Webinar titled, "In a Founders Market, Strategic Capital Thrives."

›
The law firm Morrison & Foerster (a very famous law firm based in California known as MoFo) is sponsoring a free webinar on the “buyer’s...
Wednesday, 3 November 2021

U.S. FDA Sends Letter to Push USPTO Concerning Drug Patents and Access

›
The U.S. Federal Food and Drug Administration (FDA) recently sent a letter to the U.S. Patent and Trademark Office concerning the FDA’s conc...

U.S. Federal Trade Commission Releases New Safeguards Rule for Non-Banking Financial Institutions

›
The Federal Trade Commission (FTC) in the United States has changed the regulations concerning the Safeguards Rule relating to cybersecurity...
Thursday, 30 September 2021

Essentiality Rate Inflation and Random Variability in SEP Counts with Sampling and Essentiality Checking for Top-Down FRAND Royalty Rate Setting

›
Fair, reasonable and non-discriminatory (FRAND) royalty rates for licensing standard-essential patents (SEPs) are increasingly derived “top-...
Tuesday, 7 September 2021

Modest SEP royalties on smartphones have declined and licensing is stabilizing

›
Aggregate royalty payments for licensing cellular technology standard-essential patents (SEPs) in smartphones have remained in modest single...
Tuesday, 3 August 2021

Who Benefits from the Fruit of Research from Human Cells? Civil Rights Attorney Representing Henrietta Lacks Family

›
In a fascinating turn of events, Ben Crump , the prominent civil rights attorney who represented the family of Treyvon Martin and Breonna Ta...
‹
›
Home
View web version
Powered by Blogger.